Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002089521-25-000001
Filing Date
2025-09-30
Accepted
2025-09-30 17:57:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5304
2 MICHAEL VOLKOV POA snotarizedpoa.pdf EX-1 143796
  Complete submission text file 0002089521-25-000001.txt   205509
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Subject) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-33655 | Film No.: 251361809
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 86 INNISBROOK AVENUE LAS VEGAS NV 89113
Business Address 86 INNISBROOK AVENUE LAS VEGAS NV 89113 (801)362-9766
James Russell Revocable Trust (Filed by) CIK: 0002089521 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G